Electroacupuncture Inhibits Hyperalgesia by Alleviating Inflammatory Factors in a Rat Model of Migraine

References

• Headache classification committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38:1–211. doi:10.1177/0333102417738202.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63:148–158. doi:10.1002/ana.v63:2
   PubMed Web of Science ®Google Scholar
• Louter MA, Bosker JE, van Oosterhout WP, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain. 2013;136:3489–3496. doi:10.1093/brain/awt251
   PubMed Web of Science ®Google Scholar
• Lipton RB, Fanning KM, Serrano D, et al. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology. 2015;84:688–695. doi:10.1212/WNL.0000000000001256
   PubMed Web of Science ®Google Scholar
• Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA. 2004;291:493–494.
   PubMed Web of Science ®Google Scholar
• Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;6:Cd001218.
   Google Scholar
• McDonald JL, Cripps AW, Smith PK. Mediators, receptors, and signalling pathways in the anti-inflammatory and antihyperalgesic effects of acupuncture. Evid Based Complement Alternat Med. 2015;2015:975632.
   Web of Science ®Google Scholar
• Zhang H, He S, Hu Y, et al. Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine. Acupunct Med. 2016;34:463–470.
   Web of Science ®Google Scholar
• Zhao LP, Liu L, Pei P, et al. Electroacupuncture at Fengchi (GB20) inhibits calcitonin gene-related peptide expression in the trigeminovascular system of a rat model of migraine. Neural Regen Res. 2017;12:804–811.
   Web of Science ®Google Scholar
• Burgos-Vega C, Moy J, Dussor G. Meningeal afferent signaling and the pathophysiology of migraine. Prog Mol Biol Transl Sci. 2015;131:537–564.
   Web of Science ®Google Scholar
• Russo AF. Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol. 2015;55:533–552. doi:10.1146/annurev-pharmtox-010814-124701
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46:200–207. doi:10.1111/hed.2006.46.issue-2
   PubMed Web of Science ®Google Scholar
• Yan J, Melemedjian OK, Price TJ, et al. Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain. 2012;8:6. doi:10.1186/1744-8069-8-6
   PubMed Web of Science ®Google Scholar
• Becker WJ. Acute migraine treatment in adults. Headache. 2015;55:778–793. doi:10.1111/head.12550
   PubMed Web of Science ®Google Scholar
• Burgos-Vega CC, Quigley LD, Avona A, et al. Dural stimulation in rats causes brain-derived neurotrophic factor-dependent priming to subthreshold stimuli including a migraine trigger. Pain. 2016;157:2722–2730. doi:10.1097/j.pain.0000000000000692
   Web of Science ®Google Scholar
• Li QQ, Shi GX, Yang JW, et al. Hippocampal cAMP/PKA/CREB is required for neuroprotective effect of acupuncture. Physiol Behav. 2015;139:482–490. doi:10.1016/j.physbeh.2014.12.001
   Web of Science ®Google Scholar
• Pei P, Liu L, Zhao L, et al. Effect of electroacupuncture pretreatment at GB20 on behaviour and the descending pain modulatory system in a rat model of migraine. Acupunct Med. 2016;34:127–135. doi:10.1136/acupmed-2015-010840
   Web of Science ®Google Scholar
• World Health Organization. Regional Office for the Western Pacific. WHO Standard Acupuncture Point Locations in the Western Pacific Region; Available from: https://apps.who.int/iris/handle/10665/206952. Accessed 7 January 2020.
   Google Scholar
• Siu FK, Lo SC, Leung MC.Electro-acupuncture potentiates the disulphide-reducing activities of thioredoxin system by increasing thioredoxin expression in ischemia-reperfused rat brains. Life Sci. 2005;77:386–399. doi:10.1016/j.lfs.2004.10.069
   Web of Science ®Google Scholar
• Xu X, Liu L, Zhao L, et al. Effect of electroacupuncture on hyperalgesia and vasoactive neurotransmitters in a rat model of conscious recurrent migraine. Evid Based Complement Alternat Med. 2019;2019:9512875.
   Web of Science ®Google Scholar
• Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain. 2013;154(Suppl 1):S44–53. doi:10.1016/j.pain.2013.07.021
   PubMed Web of Science ®Google Scholar
• Yu L, Wang W, Li L, et al. Inhibition of electroacupuncture on nociceptive responses of dorsal horn neurons evoked by noxious colorectal distention in an intensity-dependent manner. J Pain Res. 2019;12:231–242. doi:10.2147/JPR
   Web of Science ®Google Scholar
• Hoskin KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain. 1996;119(Pt1):249–256. doi:10.1093/brain/119.1.249
   Web of Science ®Google Scholar
• Rua R, McGavern DB. Advances in meningeal immunity. Trends Mol Med. 2018;24:542–559. doi:10.1016/j.molmed.2018.04.003
   Web of Science ®Google Scholar
• Levy D, Labastida-Ramirez A, MaassenVanDenBrink A. Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia. 2018;39:333102418771350.
   Web of Science ®Google Scholar
• Baun M, Pedersen MH, Olesen J, et al. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia. 2012;32:337–345. doi:10.1177/0333102412439354
   PubMed Web of Science ®Google Scholar
• Forsythe P. Mast cells in neuroimmune interactions. Trends Neurosci. 2019;42(1):43–55. doi:10.1016/j.tins.2018.09.006
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4:281–286. doi:10.2174/1568010054022024
   PubMedGoogle Scholar
• Schain AJ, Melo-Carrillo A, Borsook D, et al. Activation of pial and dural macrophages and dendritic cells by cortical spreading depression. Ann Neurol. 2018;83:508–521. doi:10.1002/ana.25169
   PubMed Web of Science ®Google Scholar
• Hendriksen E, van Bergeijk D, Oosting RS, et al. Mast cells in neuroinflammation and brain disorders. Neurosci Biobehav Rev. 2017;79:119–133. doi:10.1016/j.neubiorev.2017.05.001
   PubMed Web of Science ®Google Scholar
• Zhang X, Burstein R, Levy D. Local action of the proinflammatory cytokines IL-1beta and IL-6 on intracranial meningeal nociceptors. Cephalalgia. 2012;32:66–72. doi:10.1177/0333102411430848
   Web of Science ®Google Scholar
• Yucel M, Kotan D, Gurol Ciftci G, et al. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci. 2016;20:930–936.
   PubMed Web of Science ®Google Scholar
• Neeb L, Hellen P, Hoffmann J, et al. Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells. J Headache Pain. 2016;17:19. doi:10.1186/s10194-016-0609-x
   PubMed Web of Science ®Google Scholar
• Zhang XC, Kainz V, Burstein R, et al. Tumor necrosis factor-alpha induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Pain. 2011;152:140–149. doi:10.1016/j.pain.2010.10.002
   Web of Science ®Google Scholar
• Bowen EJ, Schmidt TW, Firm CS, et al. Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem. 2006;96:65–77. doi:10.1111/j.1471-4159.2005.03524.x
   Web of Science ®Google Scholar
• Balkowiec-Iskra E, Vermehren-Schmaedick A, Balkowiec A. Tumor necrosis factor-alpha increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent manner. Neuroscience. 2011;180:322–333. doi:10.1016/j.neuroscience.2011.02.028
   Web of Science ®Google Scholar
• Silberstein SD, Stirpe JC. COX inhibitors for the treatment of migraine. Expert Opin Pharmacother. 2014;15:1863–1874. doi:10.1517/14656566.2014.937704
   PubMed Web of Science ®Google Scholar
• Li C, Zhu Q, He Q, et al. Plasma levels of cyclooxygenase-2 (COX-2) and visfatin during different stages and different subtypes of migraine headaches. Med Sci Monit. 2017;23:24–28. doi:10.12659/MSM.899269
   Web of Science ®Google Scholar
• Zhang XC, Kainz V, Jakubowski M, et al. Localization of COX-1 and COX-2 in the intracranial dura mater of the rat. Neurosci Lett. 2009;452:33–36. doi:10.1016/j.neulet.2009.01.032
   PubMed Web of Science ®Google Scholar
• Mozaffari E, Doosti A, Arshi A, et al. Association of COX-2 promoter polymorphisms −765G/C and −1195A/G with migraine. Iran J Public Health. 2016;45:1625–1635.
   Web of Science ®Google Scholar
• Neeb L, Hellen P, Boehnke C, et al. IL-1beta stimulates COX-2 dependent PGE(2) synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One. 2011;6:e17360.
   PubMed Web of Science ®Google Scholar
• Fischer M, Wille G, Klien S, et al. Brain-derived neurotrophic factor in primary headaches. J Headache Pain. 2012;13:469–475.
   PubMed Web of Science ®Google Scholar
• Tanure MT, Gomez RS, Hurtado RC, et al. Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain. 2010;11:427–430.
   PubMed Web of Science ®Google Scholar
• Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci. 2006;29:507–538.
   PubMed Web of Science ®Google Scholar
• Sikandar S, Minett MS, Millet Q, et al. Brain-derived neurotrophic factor derived from sensory neurons plays a critical role in chronic pain. Brain. 2018;141:1028–1039.
   PubMed Web of Science ®Google Scholar
• Nijs J, Meeus M, Versijpt J, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets. 2015;19:565–576.
   PubMed Web of Science ®Google Scholar
• Lemos C, Mendonca D, Pereira-Monteiro J, et al. BDNF and CGRP interaction: implications in migraine susceptibility. Cephalalgia. 2010;30:1375–1382.
   PubMed Web of Science ®Google Scholar